The DEGs were associated with pathways such as the cell cycle, toxoplasmosis, and hepatocellular carcinoma (Figure 12B); biological processes such as epidermis development, skin development and gland development (Figure 12C); cellular components such as the cornified envelope, basal part of the cell and clathrin-coated endocytic vesicle (Figure 12D); and molecular functions such as cadherin binding, MHC class II protein complex binding and cell–cell adhesion mediator activity (Figure 12E). The gene discussed is CDH17; the disease is hepatocellular carcinoma.